Westport Resources Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$475K Sell
8,806
-16,274
-65% -$1.05M 0.34% 75
2016
Q2
$1.84M Sell
25,080
-583
-2% -$41.2K 0.6% 49
2016
Q1
$1.64M Sell
25,663
-549
-2% -$34.6K 0.53% 57
2015
Q4
$1.8M Sell
26,212
-1,848
-7% -$122K 0.53% 55
2015
Q3
$1.66M Sell
28,060
-413
-1% -$26.2K 0.51% 55
2015
Q2
$1.9M Sell
28,473
-299
-1% -$19.7K 0.53% 46
2015
Q1
$1.86M Sell
28,772
-1,104
-4% -$69.1K 0.51% 50
2014
Q4
$1.76M Sell
29,876
-2,647
-8% -$149K 0.47% 52
2014
Q3
$1.67M Buy
32,523
+605
+2% +$30.2K 0.46% 57
2014
Q2
$1.55M Sell
31,918
-28
-0.1% -$1.38K 0.42% 63
2014
Q1
$1.66M Sell
31,946
-377
-1% -$20.1K 0.47% 54
2013
Q4
$1.72M Buy
32,323
+255
+0.8% +$13K 0.5% 45
2013
Q3
$1.48M Buy
32,068
+4,601
+17% +$202K 0.49% 52
2013
Q2
$1.23M Buy
+27,467
New +$1.19M 0.43% 63

Other funds holding BMY

Westport Resources Management's BMY Position: Q3 2016 in Review

Westport Resources Management reduced its Bristol-Myers Squibb (BMY) stake by 65% in Q3 2016, selling an estimated $1.05M and leaving 8,806 shares worth $475K. The position accounts for 0.34% of the portfolio, ranked #75.

Westport Resources Management first reported a position in BMY in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.9M in Q2 2015. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Westport Resources Management held 8,806 shares of Bristol-Myers Squibb worth $475K as of Q3 2016.
  • Westport Resources Management sold 16,274 Bristol-Myers Squibb shares in Q3 2016, an estimated $1.05M.
  • Bristol-Myers Squibb made up 0.34% of Westport Resources Management's portfolio in Q3 2016, its #75 holding.
  • Westport Resources Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 14 quarters since.
  • Westport Resources Management's Bristol-Myers Squibb position peaked at $1.9M in Q2 2015.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Westport Resources Management's 13F filing for Q3 2016, filed 14 Nov 2016.